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Treatment of diabetic foot ulceration is very challenging, costly and often
needs to be of long duration. This leads to substantial economic burden.
Population-based research suggests that a meaningful reduction of the
incidence of amputations caused by diabetes mellitus has already been
achieved since the St. Vincent resolution in 1989. Still, it cannot be inferred
from these studies that the current preventive efforts are (cost-)effective
because reduction of amputation incidence can also be the result of improve-
ments in ulcer treatment. Nevertheless, education of people with diabetes is
widely advocated and implemented in standard practice. Despite the fact that
preventive interventions are often combined in daily practice, there is little
scientific evidence demonstrating the effect of those efforts. In systematically
reviewing the evidence, there is insufficient evidence that limited patient
education alone is effective in achieving clinically relevant reductions in ulcer
and amputation incidence. To date, high quality evidence that more complex
interventions including patient education can prevent diabetic foot ulceration
is not available either. This, however, should be interpreted as lack of evidence
rather than evidence of no effect. Future directions for research and practice
may be to concentrate preventive effort on those patients who appear to be
at highest risk of foot ulceration after careful screening and selection.
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Foot ulceration affects 15% to 25% of people with diabetes mellitus at some
point during their life [1]. Even with immediate and intensive treatment, foot
ulcers may take weeks or months to heal or may not heal at all. Moreover, 70%
of foot ulcer patients have recurrent lesions within 5 years after treatment [2].
This not only leads to physical disability and marked reduction of quality of life
but also precedes the majority of lower-extremity amputations [3–6]. Patients
with neuropathic diabetic foot ulceration have a 7% risk of amputation in the
next 10 years [7].
Treatment of diabetic foot ulcers is very challenging and often needs to be of
long duration. Because expert interference, orthopaedic appliances, antimicro-
bial drugs, topical dressings and sometimes inpatient care are required, this
results in substantial economic burden. Healthcare costs of a single ulcer are
approximately $17500 (1998 US dollars), or $30 000–33 000 in case of
lower-extremity amputation [8–10]. When loss of productivity, preventive
efforts, rehabilitation and home care are also taken into account, 7–20% of
the total expenditure on diabetes in North America and Europe are attributable
to foot ulceration [11].
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In 1989, one of the 5-year targets of the European
Declaration of St. Vincent was a 50% reduction in
amputations caused by diabetes mellitus [12]. Interna-
tional guidelines underpinned this drive by outlining foot
ulcer prevention strategies such as optimizing metabolic
control, identification and screening of people at high risk
for diabetic foot ulceration and patient education in order
to promote foot self-care [13–15]. Teaching diabetes
patients the principles of self-examination of the feet
and foot care has since long been advocated as an essen-
tial attribute of prevention strategies and is widely
implicated in clinical practice [16].
Recent population-based research suggests that
nowadays a meaningful reduction of the incidence of
amputations caused by diabetes mellitus has been achieved
[17,18]. This, however, may be attributable to improve-
ments in ulcer treatment and therefore does not necessarily
support (cost-)effectiveness of preventive efforts.
The importance of patient education is outlined by
several review articles [19–26]. Yet, only two of these
are systematic reviews; most dealt primarily with uncon-
trolled studies, and only one assessed risk of bias. Hereby,
we summarize the results of our systematic reviews,
published in the Cochrane database of systematic reviews,
of the effectiveness of education (alone or as part of a
complex intervention) targeted at people with diabetes
for the prevention of foot ulceration, on the basis of
reports of the currently available randomized controlled
trials (RCTs) [27,28].
Trials evaluating patient education
Eleven prospective RCTs which evaluated educational
programmes for preventing foot ulcers in people with
diabetes mellitus were identified after searching Ovid
MEDLINE, Ovid EMBASE, EBSCO CINAHL, the Cochrane
Wounds Group Specialized Register and the Cochrane
Central Register of Controlled Trials on 22 December
2009 (Table 1). Three studies described the effect of foot
care education as part of a general diabetes education
programme compared with usual care [29–31]. Two
studies examined the effect of a brief foot care education
session tailored to educational needs compared with no
intervention [32,33]. Finally, six studies described the
effect of intensive compared with brief educational
interventions [34–40].
Marked clinical heterogeneity precluded pooling of
outcome data. Moreover, the effect of patient education on
foot ulceration and amputations, the main outcomes of in-
terest, was assessed in only four studies. Malone et al.
reported a statistically significant benefit of 1-h group ed-
ucation for people with diabetes who were at high risk for
foot ulceration after 1-year follow-up; relative risk (RR)
amputation, 0.33 (95% CI 0.15 to 0.76); RR ulceration,
0.31 (95% CI 0.14 to 0.66) [38]. This study, however,
was at high risk of bias and may have overestimated the
effect because the outcomes were reported per limb
instead of per patient. One similar but methodologically
superior study, performed by Lincoln et al., did not con-
firm this finding. Although 71 foot ulcers and 18 amputa-
tions were observed during 1-year follow-up of diabetes
patients at high risk for foot ulceration who received 1 h
group education or written foot care instructions only,
the incidence rates did not differ between groups; RR am-
putation, 0.98 (95% CI 0.41 to 2.34); RR ulceration, 1.00
(95% CI 0.70 to 1.44) [37]. Finally, in two studies pub-
lished in three papers, too few events were observed to
detect any effect of education on ulcer incidence or ampu-
tation [29,39,40].
Patients’ foot care knowledge was improved in the
short term in five of eight RCTs in which this outcome
was assessed, as was patients’ self-reported self-care
behaviour in the short term in seven of nine RCTs.
However, in the one study with longer follow-up,
performed by Rönnemaa and colleagues, the difference
in foot care knowledge and self-care behaviour between
intervention and control group had disappeared at 7 years
[39,40]. The effects on callus, nail problems and fungal
infections were described in five of the included studies.
Only two reported temporary improvements after an
educational intervention.
Importantly, all but one of the included RCTs in this
systematic review were at high or unclear risk of bias. This
was mainly caused by insufficient reporting. Usually,
methodological flaws, such as inadequate randomization,
inadequate blinding, and selective follow-up, lead to
overestimation of the effect size, especially when subjective
outcome measures are reported, such as foot care knowl-
edge and patient behaviour. Therefore, the few positive
effects that were found should be interpreted with caution.
Trials evaluating complex
interventions
In clinical practice, patient education is often combined
with other preventive interventions. These interventions
may, like patient education, aim to improve patients’
health outcomes directly (patient-level intervention).
Examples are podiatry care, foot ulceration risk assess-
ment and motivational coaching to reinforce foot self-care
behaviours. But interventions to prevent foot ulceration
may also benefit patients indirectly through improving
healthcare professionals’ ability to provide adequate care
(care provider level intervention) or through improving
the healthcare system (structure of health care level
intervention). Examples of the first are healthcare
provider education, introduction of flow sheets for risk
assessment and referral or introduction of new screening
instruments for foot ulceration risk assessment. Examples
of healthcare structural interventions in general may
include the introduction of a multidisciplinary team
approach or measures to improve regularity of follow-up
and continuity of care [41,42].
102 J. A. N. Dorrestejin and G. D. Valk
Copyright © 2012 John Wiley & Sons, Ltd. Diabetes Metab Res Rev 2012; 28(Suppl 1): 101–106.
DOI: 10.1002/dmrr
Five prospective RCTs that evaluated combinations of
preventive strategies, not solely patient education, for
preventing foot ulcers in people with diabetes mellitus
were identified after searching Ovid MEDLINE, Ovid
EMBASE, EBSCO CINAHL, the Cochrane Wounds Group
Specialized Register and the Cochrane Central Register
of Controlled Trials on 28 May 2010 (Table 2). The study
characteristics were heterogeneous in terms of healthcare
settings, the nature of the interventions studied and
outcome measures reported.
In three studies that compared the effect of an
education-centred complex intervention with usual care
or written instructions only in diabetes patients at low
or medium risk for foot ulceration, little evidence of
benefit was found [39,40,43,44]. Two studies compared
the effect of more intensive and comprehensive complex
Table 1. Randomized controlled trials evaluating patient education for preventing diabetic foot ulceration
Study ID Setting Intervention
Participant number/
duration of follow-up Main outcomes
Mazzuca et al. [30] Primary care General diabetes education
versus usual care
532/1 year Foot care knowledge: no
difference








Foot appearance: no difference
Bloomgarden et al. [29] Primary care General diabetes education
versus usual care
345/1.5 years Self-care behaviour: no
difference
Callus, nail dystrophy and
fungal infection: no difference
Foot ulceration/amputation:
no difference
Malone et al. [38] Secondary care Intensive versus brief foot
care education
203/1 year Ulcer incidence: 0.31 (95% CI
0.14–0.66)a
Amputation rate: 0.33 (95% CI
0.15–0.76)a
Barth et al. [34] Secondary care Intensive versus brief foot
care education






Kruger et al. [36] Secondary care Intensive versus brief foot
care education
50/6months Foot care knowledge: favours
control
Self-care behaviour: favours
intervention on2out of 5 items
Hamalainen et al. [39];
Rönnemaa et al. [40]
Community-based
care
Intensive versus brief foot
care education




Presence of calcaneal callus: RR
0.96 (95% CI 0.55–1.70)a
Presence of callus in other
regions: RR 0.77 (95% CI
0.53–1.01)a
Foot ulceration/amputation:
no difference (2 vs 1)a
Frank [35] Primary care Intensive versus brief foot
care education
100/4weeks Foot care knowledge: favours
intervention
Self-care behaviour: favours












Borges and Ostwald [33] Emergency
department








Lincoln et al. [37] Secondary care Intensive versus brief foot
care education
178/1 year Self-care behaviour: favours
intervention
Ulcer incidence: RR 1.00 (95%
CI 0.70–1.44)a
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interventions with usual care in patients at high risk for
foot ulceration [45–47]. McMurray et al. reported
improvement of patients’ self-care behaviour, but the
study enrolled too few subjects to evaluate differences in
amputation incidence rates [46,47]. In a study by McCabe
et al., 2001 patients were randomized to receive a detailed
foot ulceration risk assessment followed by intensified
care for those at high risk, or care as usual [45]. The
intensive intervention comprised more intensive follow-
up, a weekly diabetic foot clinic, podiatry care, provision
of support hosiery and protective footwear and introduc-
tion of appointment reminder letters to patients. A
significant and cost-effective reduction of lower-extremity
amputations (RR 0.30; 95% CI 0.13 to 0.71) was achieved
and also a non-significant reduction of the number of foot
ulcerations (RR 0.69; 95% CI 0.41 to 1.14).
Importantly, all five RCTs assessing the effect of
complex interventions were at high risk of bias, with
hardly any of the predefined risk of bias assessment
criteria met.
Discussion
On the basis of the 11 RCTs that evaluated educational
programmes for preventing foot ulcers, we conclude that
there is insufficient robust evidence that limited patient
education alone is effective in achieving clinically relevant
reductions in ulcer and amputation incidence. Available
studies are generally underpowered and at high or
unclear risk of bias with the exception of the study by
Lincoln et al., showing no benefit of more intensive versus
brief foot care education [37]. Despite the fact that
complex interventions for preventing diabetic foot
ulceration are widely used in clinical practice worldwide,
only five RCTs evaluating the effectiveness of these types
of interventions were available. Therefore, we also
conclude that there is insufficient evidence to support
the effectiveness of complex interventions for preventing
diabetic foot ulceration. This, however, should be
interpreted as lack of evidence rather than evidence of
no effect.
More well-designed and well-powered RCTs evaluating
the effect of intensive comprehensive complex interven-
tions are urgently needed. Although large trials are costly,
the benefits in terms of reduction in costs associated with
effective treatment are potentially significant. In current
clinical practice, it may be advisable to concentrate
preventive efforts on those who appear to be at high risk
for foot ulceration after careful screening and selection
[48]. Prevention programmes should not be limited to




Table 2. Randomized controlled trials evaluating complex interventions for preventing diabetic foot ulceration
Study ID Setting Intervention
Participant number/
duration of follow-up Main outcomes




396/1 year Self-care behaviour: favours
intervention
Serious foot lesions: odds-ratio
0.41a
Amputation: no difference (1
vs 4)a
Hamalainen et al. [39];
Rönnemaa et al. [40]
Community-based care Patient education and
podiatry care versuswritten
foot care instructions only




Presence of calcaneal callus: RR
0.96 (95% CI 0.55–1.70)a
Presence of callus in other
regions: RR 0.77 (95% CI
0.53–1.01)a
Foot ulceration/amputation:
no difference (2 vs 1)a
McCabe et al. [45];
Klenerman et al. [49]
Secondary care Intensified care and
education for selected high-
risk patients versus care
as usual
2001/2 years Foot ulceration: RR 0.69 (95%
CI 0.41–1.14)a
Amputation: RR 0.30 (95% CI
0.13–0.71)a
Donohoe et al. [44] Primary care Patient foot care education
and care provider education
versus patient education on
nephropathy
1939/6months Foot care knowledge:
improvement in both groups
McMurray et al. [46];
McMurray and
McDougall [47]
Secondary care Individualized care and
education by a
multidisciplinary team
versus care as usual
83/1 year Self-care behaviour: favours
intervention
Amputation: 0 vs 5a
aIntervention versus control.
RR, relative risk.
104 J. A. N. Dorrestejin and G. D. Valk
Copyright © 2012 John Wiley & Sons, Ltd. Diabetes Metab Res Rev 2012; 28(Suppl 1): 101–106.
DOI: 10.1002/dmrr
References
1. Singh N, Armstrong DG, Lipsky BA.
Preventing foot ulcers in patients
with diabetes. JAMA 2005; 293(2):
217–228.
2. Apelqvist J, Larsson J, Agardh CD. Long-
term prognosis for diabetic patients with
foot ulcers. J Intern Med 1993; 233(6):
485–491.
3. Vileikyte L. Diabetic foot ulcers: a
quality of life issue. Diabetes Metab Res
Rev 2001; 17(4): 246–249.
4. Nabuurs-Franssen MH, Huijberts MS,
Nieuwenhuijzen Kruseman AC, Willems
J, Schaper NC. Health-related quality
of life of diabetic foot ulcer patients
and their caregivers. Diabetologia 2005;
48(9): 1906–1910.
5. Epidemiology of lower extremity
amputation in centres in Europe,
North America and East Asia: the
Global Lower Extremity Amputation
Study Group. Br J Surg 2000; 87(3):
328–337.
6. Pecoraro RE, Reiber GE, Burgess EM.
Pathways to diabetic limb amputation.
Basis for prevention. Diabetes Care
1990; 13(5): 513–521.
7. Margolis DJ, Allen-Taylor L, Hoffstad O,
Berlin JA. Diabetic neuropathic foot
ulcers and amputation. Wound Repair
Regen 2005; 13(3): 230–236.
8. Cavanagh PR, Lipsky BA, Bradbury AW,
Botek G. Treatment for diabetic foot ulcers.
Lancet 2005; 366(9498): 1725–1735.
9. Jeffcoate WJ, Harding KG. Diabetic
foot ulcers. Lancet 2003; 361(9368):
1545–1551.
10. Ragnarson Tennvall G, Apelqvist J.
Health-economic consequences of dia-
betic foot lesions. Clin Infect Dis 2004;
39(Suppl 2): S132–139.
11. Boulton AJ, Vileikyte L, Ragnarson-
Tennvall G, Apelqvist J. The global
burden of diabetic foot disease. Lancet
2005; 366(9498): 1719–1724.
12. World Health Organization (Europe)
and International Diabetes Federation
(Europe). Diabetes care and research in
Europe: the Saint Vincent declaration.
Diabet Med 1990; 7(4): 360.
13. IDF clinical guidelines task force. Global
Guideline for Type 2 Diabetes. Interna-
tional Diabetes Federation: Brussels,
2005.
14. Frykberg RG, Zgonis T, Armstrong DG,
Driver VR, Giurini JM, Kravitz SR,
Landsman AS, Lavery LA, Moore JC,
Schuberth JM, Wukich DK, Andersen C,
Vanore JV. Diabetic foot disorders. A
clinical practice guideline (2006
revision). J Foot Ankle Surg 2006; 45(5
Suppl): S1–66.
15. American Diabetes Association. Stan-
dards of medical care in diabetes—2007.
Diabetes Care 2007; 30(Suppl 1): S4–S41.
16. Edmonds ME, Foster AV. Diabetic foot
ulcers. BMJ 2006; 332(7538): 407–410.
17. Icks A, Haastert B, Trautner C, Giani G,
Glaeske G, Hoffmann F. Incidence of
lower-limb amputations in the diabetic
compared to the non-diabetic population.
Findings from nationwide insurance data,
Germany, 2005–2007. Exp Clin Endocrinol
Diabetes 2009; 117(9): 500–504.
18. Canavan RJ, Unwin NC, Kelly WF,
Connolly VM. Diabetes- and nondia-
betes-related lower extremity amputa-
tion incidence before and after the
introduction of better organized diabetes
foot care: continuous longitudinal moni-
toring using a standard method. Diabetes
Care 2008; 31(3): 459–463.
19. Armstrong DG, Harkless LB. Outcomes
of preventative care in a diabetic foot
specialty clinic. J Foot Ankle Surg 1998;
37(6): 460–466.
20. Boulton AJ. Why bother educating the
multi-disciplinary team and the patient—
the example of prevention of lower
extremity amputation in diabetes. Patient
Educ Couns 1995; 26(1–3): 183–188.
21. Edmonds ME, Van Acker K, Foster AV.
Education and the diabetic foot. Diabet
Med 1996; 13(Suppl 1): S61–64.
22. Larsson J, Apelqvist J. Towards less
amputations in diabetic patients. Inci-
dence, causes, cost, treatment, and pre-
vention—a review. Acta Orthop Scand
1995; 66(2): 181–192.
23. Levin ME. Preventing amputation in
the patient with diabetes. Diabetes Care
1995; 18(10): 1383–1394.
24. O’Meara S, Cullum N, Majid M, Sheldon
T. Systematic reviews of wound care
management: (3) antimicrobial agents
for chronic wounds; (4) diabetic foot
ulceration. Health Technol Assess 2000;
4(21): 1–237.
25. Mason J, O’Keeffe C, McIntosh A,
Hutchinson A, Booth A, Young RJ. A sys-
tematic review of foot ulcer in patients
with type 2 diabetes mellitus. I: preven-
tion. Diabet Med 1999; 16(10): 801–812.
26. Mayfield JA, Reiber GE, Sanders LJ,
Janisse D, Pogach LM. Preventive foot
care in people with diabetes. Diabetes
Care 1998; 21(12): 2161–2177.
27. Dorresteijn JA, Kriegsman DM, Assendelft
WJ, Valk GD. Patient education for pre-
venting diabetic foot ulceration. Cochrane
Database Syst Rev 2010; (5): CD001488.
28. Dorresteijn JA, Kriegsman DM, Valk GD.
Complex interventions for preventing
diabetic foot ulceration. Cochrane Data-
base Syst Rev 2010; (1): CD007610.
29. Bloomgarden ZT, Karmally W, Metzger
MJ, Brothers M, Nechemias C, Bookman
J, Faierman D, Ginsberg-Fellner F,
Rayfield E, Brown WV. Randomized,
controlled trial of diabetic patient
education: improved knowledge without
improved metabolic status. Diabetes Care
1987; 10(3): 263–272.
30. Mazzuca SA, Moorman NH, Wheeler
ML, Norton JA, Fineberg NS, Vinicor F,
Cohen SJ, Clark CM Jr. The diabetes
education study: a controlled trial of
the effects of diabetes patient education.
Diabetes Care 1986; 9(1): 1–10.
31. Rettig BA, Shrauger DG, Recker RR,
Gallagher TF, Wiltse H. A randomized
study of the effects of a home diabetes
education program. Diabetes Care 1986;
9(2): 173–178.
32. Corbett CF. A randomized pilot study of
improving foot care in home health
patients with diabetes. Diabetes Educ
2003; 29(2): 273–282.
33. Borges WJ, Ostwald SK. Improving foot
self-care behaviors with Pies Sanos.West
J Nurs Res 2008; 30(3): 325–341;
discussion 342–329.
34. Barth R, Campbell LV, Allen S, Jupp JJ,
Chisholm DJ. Intensive education
improves knowledge, compliance, and
foot problems in type 2 diabetes. Diabet
Med 1991; 8(2): 111–117.
35. Frank KL. Self-management of foot care
for patients 65 years of age or older with
diabetes. Indiana University School of
Nursing, Dec 2003.
36. Kruger S, Guthrie D. Foot care:
knowledge retention and self-care
practices. Diabetes Educ 1992; 18(6):
487–490.
37. Lincoln NB, Radford KA, Game FL,
Jeffcoate WJ. Education for secondary
prevention of foot ulcers in
people with diabetes: a randomised
controlled trial. Diabetologia 2008;
51(11): 1954–1961.
38. Malone JM, Snyder M, Anderson G,
Bernhard VM, Holloway GA Jr,
Bunt TJ. Prevention of amputation by
diabetic education. Am J Surg 1989;
158(6): 520–523; discussion 523–524.
39. Hamalainen H, Rönnemaa T, Toikka T,
Liukkonen I. Long-term effects of one
year of intensified podiatric activities
on foot-care knowledge and self-care
habits in patients with diabetes. Diabetes
Educ 1998; 24(6): 734–740.
40. Rönnemaa T, Hamalainen H, Toikka T,
Liukkonen I. Evaluation of the impact
of podiatrist care in the primary preven-
tion of foot problems in diabetic
subjects. Diabetes Care 1997; 20(12):
1833–1837.
41. Renders CM, Valk GD, Griffin S, Wagner
EH, Eijk JT, Assendelft WJ. Interventions
to improve the management of diabetes
mellitus in primary care, outpatient and
community settings. Cochrane Database
Syst Rev 2001; (1): CD001481.
42. McAuley L. Data collection checklist.
Cochrane Effective Practice and Organi-
sation of Care Review Group (EPOC),
June 2002. Available from www.epoc.
cochrane.org. [4 June 2011].
43. Litzelman DK, Slemenda CW, Langefeld
CD, Hays LM, Welch MA, Bild DE,
Ford ES, Vinicor F. Reduction of lower
extremity clinical abnormalities in
patients with non-insulin-dependent di-
abetes mellitus. A randomized,
controlled trial. Ann Intern Med 1993;
119(1): 36–41.
44. Donohoe ME, Fletton JA, Hook A,
Powell R, Robinson I, Stead JW,
Sweeney K, Taylor R, Tooke JE.
Improving foot care for people with
diabetes mellitus—a randomized con-
trolled trial of an integrated care
approach. Diabet Med 2000; 17(8):
581–587.
45. McCabe CJ, Stevenson RC, Dolan AM.
Evaluation of a diabetic foot screening
and protection programme. Diabet Med
1998; 15(1): 80–84.
46. McMurray SD, Johnson G, Davis S,
McDougall K. Diabetes education and
care management significantly improve
Patient Education on Foot Ulceration 105
Copyright © 2012 John Wiley & Sons, Ltd. Diabetes Metab Res Rev 2012; 28(Suppl 1): 101–106.
DOI: 10.1002/dmrr
patient outcomes in the dialysis unit. Am
J Kidney Dis 2002; 40(3): 566–575.
47. McMurray SD, McDougall K. Improving
diabetes foot care in the dialysis facility.
Nephrol News Issues 2003; 17(10): 57,
60–51, 65–56.
48. Jeffcoate WJ. Stratification of foot risk
predicts the incidence of new foot
disease, but do we yet know that
the adoption of routine screening
reduces it? Diabetologia 2011; 54(5):
991–993.
49. Klenerman L, McCabe C, Cogley D,
Crerand S, Laing P, White M. Screening
for patients at risk of diabetic foot ulcer-
ation in a general diabetic outpatient
clinic. Diabet Med 1996; 13(6):
561–563.
106 J. A. N. Dorrestejin and G. D. Valk
Copyright © 2012 John Wiley & Sons, Ltd. Diabetes Metab Res Rev 2012; 28(Suppl 1): 101–106.
DOI: 10.1002/dmrr
